Session » Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease
-
Abstract Number: 1075
The Impact of Race on Birth Outcomes Among Women with Autoimmune Rheumatic Diseases
-
Abstract Number: 1076
Incidence of Non-serious Infections Among Live Born Infants Born to Mothers Who Used Biologic Medications During Pregnancy for the Treatment of Autoimmune Diseases
-
Abstract Number: 1077
Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications
-
Abstract Number: 1078
Cardiovascular Risk Awareness in Patients with Rheumatic Diseases: A Case-Control Study
-
Abstract Number: 1079
Assessing Psoriatic Arthritis Treatment Trends and Patient Journeys Between 2012 and 2018
-
Abstract Number: 1080
Biosimilar Etanercept Use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: The RHUMADATA® Registry Experience
-
Abstract Number: 1082
Cancer Risk in Patients with Ankylosing Spondylitis: A Nationwide Population-based Dynamic Cohort Study from Korea
-
Abstract Number: 1084
Predicting ASDAS Inactive Disease After 6 Months of TNFi Treatment in Bio-Naive Axial Spondyloarthritis Patients Treated in Clinical Practice – Results from the EuroSpA Collaboration
-
Abstract Number: 1085
Probiotic Use and Psoriatic Arthritis Disease Activity
-
Abstract Number: 1086
Psoriatic Arthritis – Epidemiology, Incidence Rate in Psoriasis Patients, Comorbidity Profiles and Risk Factor Analysis
-
Abstract Number: 1089
Causes of Death in ANCA-Associated Vasculitis According to ANCA Type
-
Abstract Number: 1090
Identification of a Distinct Intestinal Behçet’s Disease Cluster in Japan: A Nationwide Retrospective Observational Study
-
Abstract Number: 1091
Risk of Preterm Birth by Timing of Lupus Diagnosis Among Women in the Georgia Lupus Registry
-
Abstract Number: 1092
Efficacy and Safety of Dose Adjustment Based on Patients’ Body Size in Low Dose Intravenous CYC Treatment for Rheumatic Diseases
-
Abstract Number: 1093
The US Prevalence of Inflammatory Bowel Disease and Associated Axial Pain: Data from the National Health & Nutrition Examination Survey (NHANES)
-
Abstract Number: 1094
EULAR Points to Consider for the Development, Evaluation and Implementation of Mobile Health Applications for Self-management in Patients with Rheumatic and Musculoskeletal Diseases
-
Abstract Number: 1095
The Role of Immunosuppressive Therapy in the Development of Atherosclerotic Cardiovascular Disease in Patients with Psoriatic Arthritis
-
Abstract Number: 1096
Learning the Relationships Between Psoriatic Arthritis and a Patient’s History of Musculoskeletal Symptoms from Electronic Health Records Using Bayesian Networks
-
Abstract Number: 1097
Trends in NSAIDs and Opioids Among Patients with SLE: A Population-based Study
-
Abstract Number: 1098
Epidemiology and Mortality of SLE (Systemic Lupus Erythematosus) in Hungary Based on a Nationwide Retrospective Claims Database Study
-
Abstract Number: 1099
The Safety of Pulse Therapy- Systematic Review and Meta-analysis
-
Abstract Number: 1100
Opioid Overdose Hospitalizations in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
-
Abstract Number: 1101
Development of an Algorithm to Identify Sjögren’s Syndrome Patients in the French National Healthcare Claims Database
-
Abstract Number: 1102
Estimate of Prevalence of Secondary Distal Renal Tubular Acidosis Among Patients with Sjogren’s Syndrome and Systemic Lupus Erythematosus in a US Population with Employer-Sponsored Health Insurance
-
Abstract Number: 1103
Prevalence of Diagnosed Systemic Lupus Erythematosus (SLE), Patient Healthcare Utilization and Characteristics by Major Health Insurance Types in the US
-
Abstract Number: 1104
Heritability and Familial Risk of Systemic Lupus Erythematosus in Sweden: A Population-based Case-control Study
-
Abstract Number: 1105
Relationships Among Cognitive Emotion Regulation, Body Image, Family and Marital Function and Quality of Life in Chinese Female Patients with Systemic Lupus Erythematosus